MSD in talks with 5 Indian drugmakers for clinical trial of COVID drug Molnupiravir Medical Dialogues Team30 Jun 2021 5:28 PM ISTNew Delhi: MSD Pharmaceuticals, the wholly owned subsidiary of Merck Sharp Dohme, known as Merck & Co in the US, announced that it has decided to...
Cipla gets DCGI nod to import Moderna COVID vaccine Farhat Nasim30 Jun 2021 5:15 PM ISTNew Delhi: In a breakthrough, the Drugs Controller General of India (DCGI) on Tuesday has granted permission to Cipla to import Moderna's Covid-19...
DoP directs NPPA to fix price of Darunavir, Ritonavir for Emcure Pharma Medical Dialogues Team29 Jun 2021 5:09 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP), has recently directed the National Pharmaceuticals Pricing Authority (NPPA) to fix the retail...
Moderna seeks CDSCO nod for its Covid-19 vaccine Ruchika Sharma29 Jun 2021 3:20 PM ISTNew Delhi: India''s drug regulator may soon grant restricted emergency use authorisation for Moderna''s COVID-19 vaccine, official sources said on...
Bajaj Healthcare moves patent office after Eli Lilly refuses to ink Baricitinib agreement Medical Dialogues Team28 Jun 2021 5:45 PM ISTNew Delhi: With Eli Lilly denying to ink voluntary licensing agreement for Baricitinib, Bajaj Healthcare Ltd (BHL) has approached the Indian patent...
Cipla gets USFDA nod for generic version of Brovana Ruchika Sharma23 Jun 2021 11:00 AM ISTMumbai: Drug major, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application...
NPPA fixes retail price of 3 formulations including HIV, Oncology drug Medical Dialogues Team20 Jun 2021 11:30 AM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
NPPA fixes retail price of 12 formulations, Details Medical Dialogues Team6 Jun 2021 11:30 AM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Cipla says close to committing USD 1 billion to Moderna for COVID booster shot Ruchika Sharma1 Jun 2021 11:00 AM ISTNew Delhi: Seeking fast-track approvals to bring Moderna's single-dose Covid-19 booster vaccine in India expeditiously, Cipla has requested the...
First: Indraprastha Apollo Hospital, Delhi successfully administers Casirivimab and Imdevimab antibody cocktail to COVID patient Meghna A Singhania29 May 2021 12:15 PM ISTNew Delhi, May 28, 2021: Indraprastha Apollo Hospitals, Delhi today announced that Roche India's Antibody Cocktail (Casirivimab and Imdevimab)...
NPPA panel pegs price of Hetero Labs HIV drug Darunavir Ethanolate at Rs 190.44 per tablet Medical Dialogues Team28 May 2021 5:46 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) Committee has suggested the retail price of each film-coated tablet containing...
Vaccine Status: Wait for Moderna till next year but Pfizer ready to offer in 2021 Ruchika Sharma26 May 2021 1:22 PM ISTNew Delhi: Moderna is expecting to launch a single-dose Covid-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while...
